Understanding Ozempic: What Is the Name of Ozempic for Weight Loss?

Last reviewed: July 6, 2026

Last updated: July 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic's active ingredient is semaglutide, a injectable peptide that activates GLP-1 receptors in the brain to suppress hunger signals and slow stomach emptying. Originally developed for type 2 diabetes management, semaglutide gained widespread attention for its dramatic weight loss effects in clinical trials, with patients losing an average of 15% of their body weight over 68 weeks. PlexusDx delivers compounded semaglutide injections to all 50 states, at $189/mo month-to-month, or from $149/mo on the 6-month plan with no insurance required.

What Is Semaglutide and How Does It Work

Semaglutide belongs to a drug class called GLP-1 receptor agonists, which mimic glucagon-like peptide-1, a natural hormone your body produces after eating. When semaglutide binds to GLP-1 receptors in your brain's appetite control centers, it sends signals that make you feel fuller longer and reduces cravings for food. This mechanism works independently of willpower or calorie restriction, addressing the underlying biological drivers of weight gain rather than relying on behavioral changes alone.

The medication also slows gastric emptying, meaning food moves more slowly through your stomach, extending feelings of satiety between meals. Additionally, semaglutide improves insulin sensitivity and helps regulate blood sugar levels, which can reduce energy crashes and the subsequent hunger spikes that typically drive overeating. These combined effects make semaglutide one of the most effective pharmacological tools available for sustained weight loss.

Semaglutide Brand Names: Ozempic, Wegovy, and Compounded Versions

Semaglutide is sold under multiple brand names depending on its intended use and formulation. Ozempic is the diabetes-specific brand, approved by the FDA for type 2 diabetes management at doses up to 1 mg weekly. Wegovy is the FDA-approved weight loss version, marketed for chronic weight management in adults with obesity or overweight status plus at least one weight-related condition. Both brand-name options carry high out-of-pocket costs and may face insurance restrictions or prior authorization requirements.

PlexusDx offers compounded semaglutide injections prepared by licensed 503A compounding pharmacies, providing the same active medication as brand versions but at significantly lower costs with no insurance barriers. Compounded semaglutide maintains the same efficacy profile as Ozempic and Wegovy while eliminating manufacturer markups. Your dose may need to go up as you progress through your treatment protocol, but your monthly price remains flat at $149, making long-term treatment financially predictable.

Clinical Evidence: Weight Loss Results From Semaglutide Trials

The STEP trials, which evaluated semaglutide for chronic weight management, demonstrated sustained weight loss across diverse populations. In STEP 1, participants receiving 2.4 mg semaglutide weekly lost an average of 9.2 kg (20.2 pounds) over 68 weeks, compared to 2.6 kg in the placebo group. Importantly, 86% of semaglutide-treated patients achieved at least 5% weight loss, and 69% achieved 10% or greater weight loss—thresholds associated with meaningful improvements in metabolic health and reduced cardiovascular risk.

Long-term follow-up data shows that semaglutide's effects persist as long as treatment continues, with weight regain occurring after discontinuation in most patients. This finding underscores semaglutide as a chronic therapy rather than a short-term intervention. Real-world evidence from clinical practice confirms that semaglutide produces similar weight loss patterns across different age groups, metabolic profiles, and BMI ranges, making it an inclusive option for many individuals seeking pharmacological weight management support.

Why Choose PlexusDx Compounded Semaglutide Over Brand-Name Options

Brand-name Ozempic and Wegovy typically cost $900 to $1,500 per month without insurance, and many insurers refuse to cover weight loss medications or impose restrictive prior authorization processes. PlexusDx compounded semaglutide injections start at just $189/mo (or $149/mo on the 6-month plan) from licensed 503A compounding pharmacies, eliminating cost as a barrier to access. All patients receive the same active pharmaceutical ingredient in the same injection form, with no membership fees, no insurance requirement, and availability in all 50 states.

PlexusDx also offers the Precision Peptide Genetic Test for $298, which analyzes key genetic variants in semaglutide response pathways including GIPR rs1800437. This test maps 14 metabolic pathways and 150+ genetic insights to help your provider optimize your treatment plan based on your unique biology. HSA and FSA accounts can be used to pay for both your compounded semaglutide and genetic testing, further reducing your net cost.

Side Effects, Safety, and What to Expect Starting Semaglutide

Common side effects of semaglutide include nausea, vomiting, diarrhea, and constipation, particularly during the first 2–4 weeks of treatment or after dose increases. These gastrointestinal symptoms typically resolve within days to weeks as your body adjusts, and they can be minimized by starting at low doses and increasing gradually—a practice PlexusDx providers follow carefully. Serious adverse events are rare in clinical trials, though individuals with personal or family histories of thyroid cancer or medullary thyroid carcinoma should not use semaglutide due to safety labeling warnings.

Semaglutide is administered as a once-weekly subcutaneous injection into the abdomen, thigh, or upper arm using a small pen device that most patients learn to self-inject within minutes. Dehydration and rapid weight loss (more than 1–2 pounds per week) can occasionally trigger pancreatitis or gallbladder issues, so staying well-hydrated and eating adequate protein is essential during treatment. Your PlexusDx provider will monitor your progress, adjust your dose, and address any concerns through ongoing telehealth check-ins to ensure safe and effective weight loss.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

Is semaglutide the same thing as Ozempic?

Semaglutide is the active ingredient in Ozempic, but they are not identical products. Ozempic is a specific brand formulation approved for type 2 diabetes, while semaglutide is a generic active compound used in multiple brand and compounded versions. PlexusDx compounded semaglutide injections contain the same semaglutide molecule as Ozempic but are prepared by licensed 503A pharmacies and cost significantly less.

How much weight can I expect to lose with semaglutide?

Clinical trials show average weight loss of 9–15 kg (20–33 pounds) over 68 weeks when combined with lifestyle modifications, with 86% of patients achieving at least 5% weight loss. Individual results vary based on genetics, adherence, diet, and exercise, which is why PlexusDx offers the Precision Peptide Genetic Test to identify your genetic predispositions for optimal response to semaglutide and other GLP-1 therapies.

What is the cost of semaglutide at PlexusDx?

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan with a flat-rate pricing model—your monthly cost stays the same even as your dose increases during treatment. No insurance is required, no membership fees apply, and the medication is available in all 50 states. HSA and FSA accounts are eligible for payment.

Are there serious side effects I should know about?

Most side effects are mild gastrointestinal symptoms like nausea and diarrhea that resolve within 1–4 weeks. Serious complications are rare, but individuals with personal or family history of thyroid cancer should avoid semaglutide. Dehydration and rapid weight loss can occasionally trigger pancreatitis, so staying hydrated and eating adequate protein is important during treatment.

How does the PlexusDx Precision Peptide Genetic Test help with semaglutide treatment?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.